Sbc Medical Group (SBC) revenue and earnings history
Sbc Medical Group reported revenue of $174M for fiscal 2025 (year ended Dec 31, 2025), −15.5% on the year before, and net income of $51M.
Over 2 years, from fiscal 2023 to fiscal 2025, revenue grew at a compound rate of −5.3% a year.
Revenue and net income, 3 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $174M−15.5% | $67.5M | $51M | $24.7M | $1.4M | $23.3M | $0 | $5M | — | $164M | $42.8M | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Sbc Medical Group (SBC) on OQRO.
Common questions
What was Sbc Medical Group's revenue in fiscal 2025?
$174M for the year ended Dec 31, 2025, as reported in its 10-K filed Mar 27, 2026. That is −15.5% on fiscal 2024 ($205M).
How fast has Sbc Medical Group's revenue grown?
From $194M in fiscal 2023 to $174M in fiscal 2025: a compound annual growth rate of −5.3% over 2 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure Sbc Medical Group tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.